发明申请
- 专利标题: Crystalline forms of Erlotinib HCI and formulations thereof
- 专利标题(中): 埃洛替尼HCl的结晶形式及其制剂
-
申请号: US12229682申请日: 2008-08-25
-
公开(公告)号: US20090124642A1公开(公告)日: 2009-05-14
- 发明人: Augusto Canavesi , Marco Villa , Ales Gavenda , Jiri Faustmann , Judith Aronhime , Ettore Gibatti , Alexandr Jegorov
- 申请人: Augusto Canavesi , Marco Villa , Ales Gavenda , Jiri Faustmann , Judith Aronhime , Ettore Gibatti , Alexandr Jegorov
- 主分类号: A61K31/517
- IPC分类号: A61K31/517 ; C07D239/94
摘要:
The invention provides a novel crystalline form of Erlotinib HCl, processes for its preparation, and formulations thereof.